Airox Technologies Limited IPO

The outbreak of COVID-19 led to an increase in awareness and demand of its products and an increase in the company revenue. Its cannot predict future demand for the company products or the future impact of the COVID-19 pandemic on its business, operating results, cash flows and/or financial condition. its inability to manage the company future growth may have an adverse impact on its business and financial condition.

The company is dependent on its strategic partner for the supply of molecular sieves and vessels. Any fluctuations in the price, availability and quality of the raw materials could cause delay and increase our costs which may have an adverse effect on its business and operations.

The company is dependent on continued supply of raw materials, the supply and cost of which can be subject to significant variation due to factors outside the company control.

If the company products have manufacturing defects, its may lose the company customers and may be subject to product liability claims and cause damage to its reputation, results of operations and financial condition.

The shutdown or slowdown of operations at its manufacturing facility and underutilisation of the company manufacturing capacities may have a material adverse effect on its results of operations.

Its Statutory Auditors have included a disclaimer of opinion in their audit report on the financial statements of the Company as at March 31, 2022 on the adequacy and operating effectiveness of internal financial controls.

A majority of its total revenue is attributable to sale of PSA oxygen generators. Any decrease in volume of PSA oxygen generators sold by its may have an adverse effect on our business, results of operations, financial condition and cash flows.

The company may not be able to maintain its leadership in the medical oxygen manufacturing industry which may adversely effect its business prospects and results of operations.

Its may not be able to replicate the success that the company products and systems have had in the medical oxygen manufacturing industry in the new industries its targeting for future growth.

Failure to maintain strong working relationships with healthcare professionals could adversely impact its product development and sales and marketing efforts.